日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pneumocystis Jirovecii Pneumonia: The Potential of KEX1, MSG1, and MSG2 as Key Antigens in Cytokine Release Assays.

卡氏肺囊虫肺炎:KEX1、MSG1 和 MSG2 作为细胞因子释放试验中的关键抗原的潜力

Neumann F A Ottilie, Müller Markus, Mattert Gregor, Liebig Sven, Herbst Victor, Zapf Dorinja, Kiderlen Til R, Linke Christian, Arp Franziska, Deckert P Markus, Lüth Stefan, Schwarzlose-Schwarck Sandra, Dammermann Werner, Reinwald Mark

Evaluation of three novel antigens and costimulatory agents for improvement of M. Tuberculosis specific interferon gamma release assays.

评估三种新型抗原和共刺激剂对结核分枝杆菌特异性干扰素γ释放试验的改进作用

Schwarzlose-Schwarck Sandra, Reinwald Mark, Bauer Torsten, Hentschel Florian, Kiderlen Til, Zapf Dorinja, Herbst Victor, Lüth Stefan, Krieger David, Dammermann Werner

Streptococcus pneumoniae and influenza vaccination rates in oncological patients - data from Germany

德国肿瘤患者的肺炎链球菌和流感疫苗接种率数据

Niederstein, Emma; Underwood, Journey; de Wit, Maike; Reinwald, Mark; Schwarzlose-Schwarck, Sandra; Dammermann, Werner; Deckert, P Markus; Kiderlen, Til Ramón

Herpes Zoster Vaccination Rates in Hematological and Oncological Patients-Stock Taking 2 Years after Market Approval

血液病和肿瘤患者带状疱疹疫苗接种率——上市批准两年后的现状分析

Kiderlen, Til Ramón; Trostdorf, Katrin; Delmastro, Nicola; Salomon, Arne; de Wit, Maike; Reinwald, Mark

Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus

实体瘤和血液系统恶性肿瘤患者疱疹病毒再激活的管理:德国血液学和肿瘤内科学会 (DGHO) 传染病工作组 (AGIHO) 关于 1 型单纯疱疹病毒、2 型单纯疱疹病毒和水痘-带状疱疹病毒的指南更新

Henze, Larissa; Buhl, Christoph; Sandherr, Michael; Cornely, Oliver A; Heinz, Werner J; Khodamoradi, Yascha; Kiderlen, Til Ramon; Koehler, Philipp; Seidler, Alrun; Sprute, Rosanne; Schmidt-Hieber, Martin; von Lilienfeld-Toal, Marie

Immunochemotherapy - A Missed Opportunity for Metastasized Malignant Melanoma? Reporting a Therapeutic Success with Checkpoint Inhibitor Rechallenge after Cytotoxic Immuno-Priming in a Heavily Pretreated Patient

免疫化疗——转移性恶性黑色素瘤的错失良机?一例既往接受过大量治疗的患者在细胞毒性免疫启动后再次使用检查点抑制剂治疗取得成功的病例报告

Kiderlen, Til R; Delmastro, Nicola; Jobst, Friedemann; de Wit, Maike

Essential barriers and considerations for the implementation of electronic patient-reported outcome (ePRO) measures in oncological practice: contextualizing the results of a feasibility study with existing literature

在肿瘤学实践中实施电子患者报告结局(ePRO)测量的主要障碍和注意事项:结合现有文献解读可行性研究结果

Kiderlen, Til Ramón; Schnack, Alexandra; de Wit, Maike

Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

血液学和肿瘤学中心静脉导管相关感染:德国血液学和肿瘤内科学会 (DGHO) 传染病工作组 (AGIHO) 2020 年更新的诊断、治疗和预防指南

Böll, Boris; Schalk, Enrico; Buchheidt, Dieter; Hasenkamp, Justin; Kiehl, Michael; Kiderlen, Til Ramon; Kochanek, Matthias; Koldehoff, Michael; Kostrewa, Philippe; Claßen, Annika Y; Mellinghoff, Sibylle C; Metzner, Bernd; Penack, Olaf; Ruhnke, Markus; Vehreschild, Maria J G T; Weissinger, Florian; Wolf, Hans-Heinrich; Karthaus, Meinolf; Hentrich, Marcus